- Sector
- Healthcare
- Industry
- Diagnostics & Research
- IPO Date
- May 18, 2022
Highlights
- Market Cap
- $207.19K
- Enterprise Value
- -$55.35M
- EPS (TTM)
- -$4.72
- Total Revenue (TTM)
- $113.75M
- Gross Profit (TTM)
- $66.34M
- EBITDA (TTM)
- -$55.46M
- Year Range
- $0.01 - $0.07
- ROA (TTM)
- -40.52%
- ROE (TTM)
- -58.65%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
PRENW Performance Chart
Prenetics Holding Company Limited (PRENW) is down 59.1% since the beginning of the year. At $0 per share, PRENW is trading 82.4% below its 52-week high of $0.
Loading charts...
Returns By Period
Prenetics Holding Company Limited (PRENW) has returned -59.06% so far this year and -59.47% over the past 12 months.
Prenetics Holding Company Limited
- 1D
- -23.75%
- 1M
- -21.29%
- YTD
- -59.06%
- 6M
- -42.18%
- 1Y
- -59.47%
- 3Y*
- -53.16%
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
PRENW Monthly Returns History
Based on dividend-adjusted daily data since May 18, 2022, PRENW's average daily return is +0.62%, while the average monthly return is +1.90%. At this rate, an investment would double in approximately 3.1 years.
Historically, 40% of months were positive and 60% were negative. The best month was Jun 2025 with a return of +329.7%, while the worst month was Nov 2022 at -68.7%. The longest winning streak lasted 2 consecutive months, and the longest losing streak was 4 months.
On a daily basis, PRENW closed higher 26% of trading days. The best single day was Jun 18, 2025 with a return of +110.1%, while the worst single day was Jun 26, 2023 at -57.0%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -0.00% | -34.56% | -8.72% | -21.35% | 2.86% | -15.28% | -59.06% | ||||||
| 2025 | 25.64% | 41.84% | -23.74% | -12.26% | -2.15% | 329.67% | -15.86% | -24.32% | 39.76% | -38.22% | 22.79% | 12.88% | 282.05% |
| 2024 | 0.40% | -38.00% | 3.23% | 17.19% | -9.72% | 105.29% | -27.34% | -0.99% | 8.00% | 1.85% | -0.00% | -29.09% | -21.69% |
| 2023 | -24.23% | 23.97% | -31.07% | 19.15% | -3.65% | -31.42% | -37.35% | 0.59% | -22.03% | -59.75% | -51.55% | 27.69% | -93.76% |
| 2022 | -5.59% | 8.09% | -27.57% | -1.60% | 52.44% | -14.02% | -68.73% | 31.98% | -60.66% |
Benchmark Metrics
Prenetics Holding Company Limited has an annualized alpha of 394.16%, beta of -0.18, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since May 18, 2022.
- This stock participated in 135.56% of S&P 500 Index downside but only -104.09% of its upside - more exposed to losses than it benefited from rallies.
- Beta of -0.18 may look defensive, but with R2 of 0.00 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 394.16%
- Beta
- -0.18
- R²
- 0.00
- Upside Capture
- -104.09%
- Downside Capture
- 135.56%
Return for Risk
Risk / Return Rank
PRENW ranks 29 for risk / return — below 29% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Prenetics Holding Company Limited (PRENW) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PRENW | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.36 | ||
| Sortino ratioReturn per unit of downside risk | -2.17 | ||
| Omega ratioGain probability vs. loss probability | 1.09 | 1.37 | -0.28 |
| Calmar ratioReturn relative to maximum drawdown | -0.82 | 2.78 | -3.61 |
| Martin ratioReturn relative to average drawdown | -1.26 | 12.44 | -13.70 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Prenetics Holding Company Limited. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Prenetics Holding Company Limited was 99.00%, occurring on Feb 23, 2024. The portfolio has not yet recovered.
The current Prenetics Holding Company Limited drawdown is 97.74%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2024 bear market2024 | -99.00%Feb 2024 | 1y 5mo | — | 3y 9moSep 2022 - now |
Bear market2022 | -46.67%Aug 2022 | 3mo | 22d | 3mo 22dMay 2022 - Sep 2022 |
Bear market2022 | -28.18%May 2022 | 1d | 6d | 7dMay 2022 - May 2022 |
Drawdown Indicators
| PRENW | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.00% | -56.78% | -42.22% |
Max Drawdown (1Y)Largest decline over 1 year | -72.77% | -9.10% | -63.67% |
Max Drawdown (3Y)Largest decline over 3 years | -95.45% | -18.90% | -76.55% |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -97.74% | -1.80% | -95.94% |
Average DrawdownAverage peak-to-trough decline | -84.60% | -10.71% | -73.89% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 47.39% | 2.03% | +45.36% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Prenetics Holding Company Limited over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Prenetics Holding Company Limited is priced in the market compared to other companies in the Diagnostics & Research industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for PRENW relative to other companies in the Diagnostics & Research industry. Currently, PRENW has a P/S ratio of 0.0. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for PRENW in comparison with other companies in the Diagnostics & Research industry. Currently, PRENW has a P/B value of 0.0. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with PRENW
Add Prenetics Holding Company Limited to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with PRENW